NKTT-320

N/A

Report date: 2025/01/26 15:12:23

Base Information

Drug NameNKTT-320
Drug Alias NameNKT-14mNKT-cell antibody (NKT Therapeutics)natural killer T cell antibody (NKT Therapeutics)NKTT-320
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunomodulatorsNatural killer T-lymphocyte stimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNkt Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNkt Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A